GBR-13119 is a psychostimulant and dopamine re-uptake inhibitor.[1]

References

  1. ^ Kilbourn, Michael R.; Phil S. Sherman; Teresa Pisani (1992). "Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site" (PDF). European Journal of Pharmacology. 216 (1): 109–112. doi:10.1016/0014-2999(92)90216-Q. hdl:2027.42/30038. ISSN 0014-2999. PMID 1526249.